Nirav Shah, PhD

Senior Scientist
Janssen Research and Development, LLC

Nirav Shah is a PK/PD Scientist in the Preclinical Sciences and Translational Safety (PSTS) department at Janssen R&D. He earned his Ph.D. in Pharmacology from The Ohio State University in 2018 followed by a postdoctoral position in the Center for Pharmacometrics and Systems Pharmacology at the University of Florida. His areas of focus at Janssen include T-cell-redirecting CD3 bispecifics, CD28 costimulation, and novel oral and targeted delivery of biologics.

Disclosure information not submitted.

Presentation(s):

• Retrospective Look at Translational Considerations for T-cell Redirectors

  Tuesday, October 18, 2022
  10:30 AM – 11:00 AM ET

• Rapid Fire: Breaking Through Barriers in Preclinical Development To Improve Clinical Translation (BM)

  Tuesday, October 18, 2022
  3:00 PM – 4:00 PM ET